Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Turecek

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Blood|October 24, 2002
Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressinRosemarie A Reiter, Paul Knöbl, Katalin Varadi, et al.
British Journal of Haematology|December 11, 2002
Activation and inactivation of human factor X by proteases derived from Ficus caricaGünter Richter, Hans Peter Schwarz, Friedrich Dorner, et al.
Blood Reviews|June 24, 2019
Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factorFlora Peyvandi, Peter Kouides, Peter L Turecek, et al.
Journal of Pharmaceutical Sciences|February 13, 2016
PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved DrugsPeter L Turecek, Mary J Bossard, Freddy Schoetens, et al.
International Journal of Toxicology|September 8, 2025
Evaluation of Plasma Polyethylene Glycol (PEG) Levels in a Healthy Adult PopulationKlaus Kubesch, Christian Lubich, Daniel Mascher, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 30, 2020
Biological mechanisms underlying inter-individual variation in factor VIII clearance in haemophiliaPeter L Turecek, Jill M Johnsen, Steven W Pipe, et al.
Frontiers in Immunology|August 15, 2022
Polyethylene glycol 20 kDa-induced vacuolation does not impair phagocytic function of human monocyte-derived macrophagesAnne Schoenbrunn, Kerstin Juelke, Birgit M Reipert, et al.
Proteomics|April 20, 2006
Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoformsDaniel Kolarich, Alfred Weber, Peter L Turecek, et al.
Research and Practice in Thrombosis and Haemostasis|March 1, 2024
Clot formation and fibrinolysis assays reveal functional differences among hemostatic agents in hemophilia A plasmaLori A Holle, Jacob C Pantazis, Peter L Turecek, et al.
Expert Opinion on Therapeutic Targets|January 20, 2026
The IL-33 receptor ST2 as a therapeutic target for hemophilic arthropathyAlexander G Lawrence, James S O'Donnell, Peter L Turecek, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Blood|October 24, 2002
Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressinRosemarie A Reiter, Paul Knöbl, Katalin Varadi, et al.
British Journal of Haematology|December 11, 2002
Activation and inactivation of human factor X by proteases derived from Ficus caricaGünter Richter, Hans Peter Schwarz, Friedrich Dorner, et al.
Blood Reviews|June 24, 2019
Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factorFlora Peyvandi, Peter Kouides, Peter L Turecek, et al.
Journal of Pharmaceutical Sciences|February 13, 2016
PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved DrugsPeter L Turecek, Mary J Bossard, Freddy Schoetens, et al.
International Journal of Toxicology|September 8, 2025
Evaluation of Plasma Polyethylene Glycol (PEG) Levels in a Healthy Adult PopulationKlaus Kubesch, Christian Lubich, Daniel Mascher, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 30, 2020
Biological mechanisms underlying inter-individual variation in factor VIII clearance in haemophiliaPeter L Turecek, Jill M Johnsen, Steven W Pipe, et al.
Frontiers in Immunology|August 15, 2022
Polyethylene glycol 20 kDa-induced vacuolation does not impair phagocytic function of human monocyte-derived macrophagesAnne Schoenbrunn, Kerstin Juelke, Birgit M Reipert, et al.
Proteomics|April 20, 2006
Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoformsDaniel Kolarich, Alfred Weber, Peter L Turecek, et al.
Research and Practice in Thrombosis and Haemostasis|March 1, 2024
Clot formation and fibrinolysis assays reveal functional differences among hemostatic agents in hemophilia A plasmaLori A Holle, Jacob C Pantazis, Peter L Turecek, et al.
Expert Opinion on Therapeutic Targets|January 20, 2026
The IL-33 receptor ST2 as a therapeutic target for hemophilic arthropathyAlexander G Lawrence, James S O'Donnell, Peter L Turecek, et al.
Pageof 10